Edelman Steven Biography and Net Worth



Dr. Edelman was elected to our Board of Directors in September 2016. Dr. Edelman has served as a Professor of Medicine in the Division of Endocrinology, Diabetes & Metabolism at the University of California, San Diego and the Veterans Affairs Healthcare System of San Diego since 2001. He also currently serves as a director of Taking Control of Your Diabetes, a non-profit organization promoting patient education, motivation and self advocacy that he founded in 1995, and the Diabetes Care Clinic VA Medical Center. Dr. Edelman received his B.A. and his M.S. in Biology from the University of California, Los Angeles and his M.D. from the University of California, Davis.

What is Edelman Steven's net worth?

The estimated net worth of Edelman Steven is at least $546.12 thousand as of November 10th, 2025. Dr. Steven owns 74,708 shares of Senseonics Holdings, Inc. Common Stock stock worth more than $546,115 as of June 17th. This net worth approximation does not reflect any other investments that Dr. Steven may own. Learn More about Edelman Steven's net worth.

How do I contact Edelman Steven?

The corporate mailing address for Dr. Steven and other Senseonics Holdings, Inc. Common Stock executives is 20451 SENECA MEADOWS PARKWAY, GERMANTOWN, MD, 20876. Senseonics Holdings, Inc. Common Stock can also be reached via phone at (301) 515-7260 and via email at [email protected]. Learn More on Edelman Steven's contact information.

Has Edelman Steven been buying or selling shares of Senseonics Holdings, Inc. Common Stock?

Edelman Steven has not been actively trading shares of Senseonics Holdings, Inc. Common Stock in the last ninety days. Most recently, on Monday, November 10th, Edelman Steven bought 10,000 shares of Senseonics Holdings, Inc. Common Stock stock. The stock was acquired at an average cost of $6.55 per share, with a total value of $65,500.00. Following the completion of the transaction, the director now directly owns 74,708 shares of the company's stock, valued at $489,337.40. Learn More on Edelman Steven's trading history.

Who are Senseonics Holdings, Inc. Common Stock's active insiders?

Senseonics Holdings, Inc. Common Stock's insider roster includes Timothy Goodnow (CEO), Sharon Larkin (Director), Douglas Roeder (Director), Edelman Steven (Director), and Frederick Sullivan (CFO). Learn More on Senseonics Holdings, Inc. Common Stock's active insiders.

Are insiders buying or selling shares of Senseonics Holdings, Inc. Common Stock?

In the last twelve months, Senseonics Holdings, Inc. Common Stock insiders bought shares 6 times. They purchased a total of 87,826 shares worth more than $510,932.11. The most recent insider tranaction occured on May, 12th when Director Douglas A Roeder bought 22,686 shares worth more than $126,134.16. Insiders at Senseonics Holdings, Inc. Common Stock own 4.7% of the company. Learn More about insider trades at Senseonics Holdings, Inc. Common Stock.

Information on this page was last updated on 5/12/2026.

Edelman Steven Insider Trading History at Senseonics Holdings, Inc. Common Stock

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/10/2025Buy10,000$6.55$65,500.0074,708View SEC Filing Icon  
See Full Table

Edelman Steven Buying and Selling Activity at Senseonics Holdings, Inc. Common Stock

This chart shows Edelman Steven's buying and selling at Senseonics Holdings, Inc. Common Stock by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Senseonics Holdings, Inc. Common Stock Company Overview

Senseonics Holdings, Inc. Common Stock logo
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
Read More

Today's Range

Now: $6.95
Low: $6.92
High: $7.42

50 Day Range

MA: $6.51
Low: $5.00
High: $7.43

2 Week Range

Now: $6.95
Low: $4.79
High: $12.58

Volume

289,887 shs

Average Volume

617,260 shs

Market Capitalization

$290.61 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.04